TFS
REGN icon

TrustCore Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

TrustCore Financial Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$24.5K Hold
34
– – ﹤0.01% 571
2022
Q3 		$23K Hold
34
– – ﹤0.01% 589
2022
Q2 		$20K Hold
34
– – ﹤0.01% 641
2022
Q1 		$24K Hold
34
– – ﹤0.01% 621
2021
Q4 		$21K Buy
+34
New +$20.9K ﹤0.01% 595
2018
Q3 		– Sell
-9
Closed -$3K – 946
2018
Q2 		$3K Buy
+9
New +$2.81K ﹤0.01% 770

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TrustCore Financial Services's REGN Position: Q4 2022 in Review

TrustCore Financial Services held its Regeneron Pharmaceuticals (REGN) position steady in Q4 2022 at 34 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #571.

TrustCore Financial Services first reported a position in REGN in Q2 2018 and has held it in 6 quarters since. 1,159 funds tracked by Wall St. Rank hold REGN as of Q4 2022.

  • TrustCore Financial Services held 34 shares of Regeneron Pharmaceuticals worth $24.5K as of Q4 2022.
  • TrustCore Financial Services left its Regeneron Pharmaceuticals share count unchanged in Q4 2022.
  • Regeneron Pharmaceuticals made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #571 holding.
  • TrustCore Financial Services first reported a position in Regeneron Pharmaceuticals in Q2 2018 and has held it in 6 quarters since.
  • 1,159 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.